SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -45.5% | 190 | -55.0% | 0.00% | -42.9% |
| Q2 2021 | $33,000 | +17.9% | 422 | +10.5% | 0.01% | +16.7% |
| Q1 2021 | $28,000 | -22.2% | 382 | +78.5% | 0.01% | -25.0% |
| Q4 2020 | $36,000 | +9.1% | 214 | -9.3% | 0.01% | -11.1% |
| Q3 2020 | $33,000 | -2.9% | 236 | +9.8% | 0.01% | -18.2% |
| Q2 2020 | $34,000 | +41.7% | 215 | -13.0% | 0.01% | +10.0% |
| Q1 2020 | $24,000 | -7.7% | 247 | +24.1% | 0.01% | +42.9% |
| Q4 2019 | $26,000 | +2500.0% | 199 | +1143.8% | 0.01% | – |
| Q3 2019 | $1,000 | -96.0% | 16 | -90.2% | 0.00% | -100.0% |
| Q2 2019 | $25,000 | – | 164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |